Aug 22, 2023, 09:09
Neha Mehta-Shah: Absolutely honored and so grateful to receive this SIP grant to study an oral EZH2 inhibitor in CTCL.
Neha Mehta-Shah, an Associate Professor at Washington University in St. Louis, recently tweeted:
“Absolutely honored and so grateful to receive this SIP grant to study an oral EZH2 inhibitor in CTCL. Well-tolerated, oral effective therapies are of tremendous need in this population. Working with Payton Laboratory, George P. Souroullas, on correlatives and study quality of life Amy Musiek”
Source: Neha Mehta-Shah/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43